Anhui Anke Biotechnology (Group) Co., Ltd. (SHE:300009)
China · Delayed Price · Currency is CNY 8.61
+0.29 (3.49%)
Sep 30, 2026, 3:04 PM CST
SHE:300009 Market Cap
SHE:300009 has a market cap or net worth of 14.35 billion as of October 2, 2026. Its market cap has decreased by -13.96% in one year.
Market Cap
14.35B
Enterprise Value
13.17B
Revenue
2.45B
Ranking
n/a
PE Ratio
20.50
Stock Price
8.61
ChartMarket Cap Chart
Since October 30, 2009, SHE:300009's market cap has increased from 4.21B to 14.35B, an increase of 241.22%. That is a compound annual growth rate of 7.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 14.35B | -10.10% |
| Dec 31, 2025 | 15.97B | 10.76% |
| Dec 31, 2024 | 14.41B | -15.68% |
| Dec 29, 2023 | 17.09B | 9.42% |
| Dec 30, 2022 | 15.62B | -27.16% |
| Dec 31, 2021 | 21.45B | 7.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HitGen | 17.91B |
| Sinocelltech Group | 17.43B |
| BrightGene Bio-Medical Technology | 15.59B |
| GemPharmatech | 15.52B |
| Shanghai Medicilon | 14.16B |
| Nanjing Vazyme Biotech | 14.08B |
| Jinyu Bio-technology | 12.65B |
| Chengdu Olymvax Biopharmaceuticals | 12.65B |